The Trump administration has eased access to unproven peptide drugs favored by Health Secretary Robert F. Kennedy Jr., sparking concerns about the safety and efficacy of these substances.
As I read about the Trump administration's decision to ease access to unproven peptide drugs, my mind keeps going back to the what-ifs. What if someone had noticed the lack of scientific evidence supporting their use sooner? What if they had faced consequences for their actions earlier on?
The Peptide Market
The global peptide market is expected to nearly triple to $11.2 billion by 2035, with synthetic peptides like GLP-1s being created to mimic natural substances.
Trump Admin Touts Unproven Peptide with $11 Billion Potential
BPC-157, a synthetic version of a gastric peptide made in the stomach, has been explored for tissue repair, muscle growth, pain relief, arthritis, and bone and joint support. However, there is limited scientific evidence supporting its use for these purposes.
BPC-157: A Synthetic Peptide at the Center of Controversy
The numbers are staggering - $11.2 billion is the projected value of the global peptide market by 2035, a nearly threefold increase from current estimates. This growth is largely driven by synthetic peptides like GLP-1s, which mimic natural substances in the body.
One of the most popular peptides being touted as part of the "Wolverine shot" or "Wolverine stack" is BPC-157, a synthetic version of a gastric peptide made in the stomach. It's being explored for tissue repair, muscle growth, pain relief, arthritis, and bone and joint support - but what about the risks?
There's still much that's unknown about the long-term effects of using these peptides, particularly when combined as part of the "Wolverine shot". The Trump administration's decision to ease access to unproven peptide drugs has raised concerns among experts, who warn that the scientific evidence supporting their use is limited at best.
TB-500, modeled after Thymosin Beta-4, a naturally occurring protein, has also been touted as having potential benefits. But what about the risks?
Source: Google News
